Log in to save to my catalogue

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in...

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c4755a4d8487406da572d311c6d94085

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials

About this item

Full title

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2022-08, Vol.50 (8), p.3000605221116760-3000605221116760

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

Subjects

More information

Scope and Contents

Contents

Objective
To conduct a meta-analysis to compare different dosing scalars of sugammadex in a morbidly obese population for reversal of neuromuscular blockade (NMB).
Methods
PubMed®, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials (CENTRAL) and Google Scholar were searched for relevant randomized controlled trials (RCTs) c...

Alternative Titles

Full title

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c4755a4d8487406da572d311c6d94085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c4755a4d8487406da572d311c6d94085

Other Identifiers

ISSN

0300-0605

E-ISSN

1473-2300

DOI

10.1177/03000605221116760

How to access this item